Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Conditions:   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Large Cell Lymphoma;   Refractory Childhood Acute Lymphoblastic Leukemia;   Refractory Childhood Hodgkin Lymphoma;   Refractory Childhood Malignant Ger m Cell Neoplasm;   Recurrent Childhood Brain Tumor;   Recurrent Childhood Brainstem Glioma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childh ood Gliosarcoma;   Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Refractory Childhood Malignant Solid Neoplasm;   Recurrent Childhood Malignant Solid Neoplasm;   Recurrent Childhood Malignant Neoplasm;   Refractory Childhood Malignant Neoplasm Intervention:   Sponsors:   Florida International University;   Nicklaus Children's Hospital f/k/a Miami Children's Hospital;   First Ascent Biomedical, Inc.;   National Institute on Minority Health and Health Disparities (NIMHD) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials